BLSM · Company research
BlossomHill Therapeutics, Inc. (BLSM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| BlossomHill Therapeutics (NASDAQ:BLSM) Stock Price Down 7% - What's Next? - MarketBeat | BlossomHill Therapeutics (NASDAQ:BLSM) Stock Price Down 7% - What's Next? MarketBeat | View source ↗ | MarketBeat | Oct 13, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) Sees Significant Increase in Short Interest - MarketBeat | BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) Sees Significant Increase in Short Interest MarketBeat | View source ↗ | MarketBeat | Oct 11, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics (NASDAQ:BLSM) Shares Down 6.6% - Here's What Happened - MarketBeat | BlossomHill Therapeutics (NASDAQ:BLSM) Shares Down 6.6% - Here's What Happened MarketBeat | View source ↗ | MarketBeat | Oct 6, 2026 | neutral | 0 | 0.6 |
| Blossomhill Therapeutics Inc (BLSM:UW): Stock Price, Quote and News - BNN Bloomberg | Blossomhill Therapeutics Inc (BLSM:UW): Stock Price, Quote and News BNN Bloomberg | View source ↗ | BNN Bloomberg | Sep 30, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics (NASDAQ:BLSM) Stock Falls 4.9% - Here's What Happened - MarketBeat | BlossomHill Therapeutics (NASDAQ:BLSM) Stock Falls 4.9% - Here's What Happened MarketBeat | View source ↗ | MarketBeat | Sep 30, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics (NASDAQ:BLSM) Shares Climb 5.6% - Here's Why - MarketBeat | BlossomHill Therapeutics (NASDAQ:BLSM) Shares Climb 5.6% - Here's Why MarketBeat | View source ↗ | MarketBeat | Sep 28, 2026 | neutral | 0 | 0.6 |
| An experimental cancer drug shrank tumors in models of pancreatic, lung and colorectal cancer. - Stock Titan | An experimental cancer drug shrank tumors in models of pancreatic, lung and colorectal cancer. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics Ord Shs (BLSM) Balance Sheet - TradingKey | BlossomHill Therapeutics Ord Shs (BLSM) Balance Sheet TradingKey | View source ↗ | TradingKey | Sep 24, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results - Stock Titan | BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results Stock Titan | View source ↗ | Stock Titan | Sep 18, 2026 | neutral | 0 | 0.6 |
| Biotech Stocks At 52-Week Highs - NEO, BLSM, RVMD, ORMP, CADL - RTTNews | Biotech Stocks At 52-Week Highs - NEO, BLSM, RVMD, ORMP, CADL RTTNews | View source ↗ | RTTNews | Aug 28, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Chief Financial Officer of $BLSM Buys 700 Shares - Quiver Quantitative | Insider Purchase: Chief Financial Officer of $BLSM Buys 700 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 10, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Chief Financial Officer of $BLSM Buys 700 Shares - Quiver Quantitative | Insider Purchase: Chief Financial Officer of $BLSM Buys 700 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 10, 2026 | neutral | 0 | 0.6 |
| Cancer drug developer BlossomHill slips post IPO (BLSM:NASDAQ) - Seeking Alpha | Cancer drug developer BlossomHill slips post IPO (BLSM:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 7, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics Aims For $125 Million IPO On Cancer Treatment Pipeline Promise - Seeking Alpha | BlossomHill Therapeutics Aims For $125 Million IPO On Cancer Treatment Pipeline Promise Seeking Alpha | View source ↗ | Seeking Alpha | Aug 5, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics (BLSM) IPO & Stock Profile - Renaissance Capital | BlossomHill Therapeutics (BLSM) IPO & Stock Profile Renaissance Capital | View source ↗ | Renaissance Capital | Jul 17, 2026 | neutral | 0 | 0.6 |
| BlossomHill Therapeutics files for Nasdaq IPO under ticker BLSM - Investing.com | BlossomHill Therapeutics files for Nasdaq IPO under ticker BLSM Investing.com | View source ↗ | Investing.com | Jul 17, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.